IP Library Granted Patent US 9,360,446
Granted Patent B2
US 9,360,446 · App. 14/061,482 · Granted Jun 7, 2016

Methods and systems for measuring and using the oxidation-reduction potential of a biological sample

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,360,446
App. No.
14/061,482
Granted
Jun 7, 2016
Kind
B2
Abstract

Methods and systems for measuring and using the oxidation-reduction characteristics of a biological sample are provided. The system generally includes a test strip and a readout device. A fluid sample is placed in the test strip, and the test strip is in turn operatively connected to the readout device. The readout device provides a controlled current that is sent across the fluid in the sample chamber. In addition, the readout device identifies an inflection point or transition time at which the voltage between contacts of the test strip is changing at the highest rate. The oxidation-reduction capacity of the sample is taken as the integral of the current profile from the time at which current begins to be supplied to the sample to the identified transition time.

Claims (32)

1. A method for diagnosing, evaluating or monitoring a subject for brain injury, comprising:

a. measuring a capacity oxidation-reduction potential (cORP) of the subject, wherein measuring the cORP of the subject comprises:

passing a current through a fluid sample obtained from the subject; and

monitoring a voltage across the fluid sample while passing the current through the fluid sample over at least a first period of time;

determining a quantity of charge passed to the fluid sample during the first period of time to obtain the cORP of the subject;

b. comparing the measured cORP to a reference value to determine a brain injury status of the subject, wherein the reference value is one of:

1) a normal reference value, wherein a measured cORP value that is less than the normal reference value indicates a risk of a brain injury; and

2) a brain injury reference value, wherein a measured cORP value that is greater than the brain injury reference value indicates an absence of a brain injury; and

c. treating the subject based on the brain injury status of the subject.

2. The method of claim 1 , wherein the reference value is a normal reference value taken from a sample obtained from a subject having no brain injury.

3. The method of claim 1 , wherein the reference value is a brain injury reference value taken from a sample obtained from a subject having a brain injury.

4. The method of claim 1 , wherein the reference value is a self reference value taken from the subject at an earlier time.

5. The method of claim 1 , wherein the brain injury status of the subject is that the subject has a brain injury.

6. The method of claim 1 , wherein the step of treating is selected from the group consisting of medication, surgery and rehabilitation.

7. The method of claim 1 , wherein the brain injury status of the subject is that the subject does not have a brain injury.

8. The method of claim 1 , wherein the step of treating is not providing treatment for a brain injury.

9. The method of claim 1 , wherein measuring the cORP of the subject further includes identifying an inflection point in the monitored voltage across the fluid sample.

10. The method of claim 9 , wherein the first period of time extends from a start time to the identified inflection point.

11. The method of claim 10 , wherein the quantity of charge passed to the fluid sample is determined by integrating the current over the first period of time.

12. The method of claim 11 , wherein the start time is a time at which the monitored voltage has stabilized.

13. A method for diagnosing, evaluating or monitoring a subject for a brain injury condition, comprising:

a. measuring a capacity oxidation-reduction potential (cORP) of the subject, wherein measuring the cORP of the subject comprises:

passing a current through a fluid sample obtained from the subject; and

monitoring a voltage across the fluid sample while passing the current through the fluid sample over at least a first period of time;

determining a quantity of charge passed to the fluid sample during the first period of time to obtain the cORP of the subject; and

b. comparing the measured cORP to a reference value for the brain injury condition to determine a brain injury condition status of the subject, wherein the reference value is one of:

1) a normal reference value, wherein a measured cORP value that is less than the normal reference value indicates a risk of a brain injury condition; and

2) a brain injury reference value, wherein a measured cORP value that is greater than the brain injury reference value indicates an absence of a brain injury condition.

14. The method of claim 13 , wherein measuring the cORP of the subject further includes identifying an inflection point in the monitored voltage across the fluid sample.

15. The method of claim 14 , wherein the first period of time extends from a start time to the identified inflection point.

16. The method of claim 15 , wherein the quantity of charge passed to the fluid sample is determined by integrating the current over the first period of time.

17. The method of claim 16 , wherein the start time is a time at which the monitored voltage has stabilized.

Assignments (3)
MERGER Recorded Aug 20, 2015
From: LUOXIS DIAGNOSTICS, INC.
To: ROSEWIND CORPORATION
Reel/Frame 036380/0283 →
CERTIFICATES OF CONVERSION AND INCORPORATION Recorded Aug 20, 2015
From: ROSEWIND CORPORATION
To: AYTU BIOSCIENCE, INC.
Reel/Frame 036400/0479 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 29, 2014
From: BAR-OR, RAPHAEL; BAR-OR, DAVID; RAEL, LEONARD
To: LUOXIS DIAGNOSTICS, INC.
Reel/Frame 034594/0395 →